The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Javlor

25 milligram(s)/millilitre Concentrate for solution for infusion

Pierre Fabre MedicamentEU/1/09/550/1-12

Main Information

Trade NameJavlor
Active SubstancesVinflunine ditartrate
Strength25 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderPierre Fabre Medicament
Licence NumberEU/1/09/550/1-12

Group Information

ATC CodeL01CA Vinca alkaloids and analogues
L01CA05 vinflunine

Status

Authorised/WithdrawnAuthorised
Licence Issued21/09/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back